MAM
IMUX icon

Meeder Asset Management’s Immunic IMUX Stock Holding History

Meeder Asset Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-27
Closed -$3K – 2263
2020
Q2 		$3K Sell
27
-10
-27% -$1.02K ﹤0.01% 1671
2020
Q1 		$2K Buy
37
+16
+76% +$1.29K ﹤0.01% 2091
2019
Q4 		$2K Buy
21
+6
+40% +$499 ﹤0.01% 2017
2019
Q3 		$1K Sell
15
-1
-6% -$134 ﹤0.01% 2065
2019
Q2 		$2K Buy
16
+1
+7% +$131 ﹤0.01% 1862
2019
Q1 		$1K Hold
15
– – ﹤0.01% 1621
2018
Q4 		$1K Buy
+15
New +$1.76K ﹤0.01% 1633
2018
Q3 		– Sell
-1
Closed -$2.68K – 1610
2018
Q2 		$2.68K Hold
1
– – ﹤0.01% 1376
2018
Q1 		$4K Sell
1
-1
-50% -$2.29K ﹤0.01% 1278
2017
Q4 		$5K Sell
2
-1
-33% -$2.21K ﹤0.01% 1309
2017
Q3 		$5K Buy
3
+1
+50% +$1.3K ﹤0.01% 1263
2017
Q2 		$3K Sell
2
-1
-33% -$1.33K ﹤0.01% 1326
2017
Q1 		$5K Sell
3
-3
-50% -$5.49K ﹤0.01% 1073
2016
Q4 		$10K Buy
+6
New +$13.1K ﹤0.01% 755

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Meeder Asset Management's IMUX Position: Q3 2020 in Review

Meeder Asset Management sold out of Immunic (IMUX) in Q3 2020, closing a stake of 27 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in IMUX in Q4 2016 and held it in 14 quarters. The position peaked at $10K in Q4 2016. 66 funds tracked by Wall St. Rank hold IMUX as of Q3 2020.

  • Meeder Asset Management reported no remaining Immunic position as of Q3 2020 after selling out during the quarter.
  • Meeder Asset Management sold 27 Immunic shares in Q3 2020, an estimated $3K.
  • Meeder Asset Management first reported a position in Immunic in Q4 2016 and held it in 14 quarters.
  • Meeder Asset Management's Immunic position peaked at $10K in Q4 2016.
  • 66 funds tracked by Wall St. Rank held Immunic as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.